Australian (ASX) Healthcare Facilities Industry Analysis

Industry Valuation and Performance

Has the Australian Healthcare Facilities Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 10 May 2026	AU$10.7b	AU$20.2b	AU$326.2m	31x	32.7x	0.5x
Tue, 07 Apr 2026	AU$11.1b	AU$20.2b	AU$326.2m	32.8x	33.9x	0.5x
Thu, 05 Mar 2026	AU$12.2b	AU$20.2b	AU$326.2m	36x	37.3x	0.6x
Sat, 31 Jan 2026	AU$10.7b	AU$19.2b	AU$80.8m	41.4x	132x	0.6x
Mon, 29 Dec 2025	AU$10.5b	AU$19.2b	AU$80.8m	43.4x	130x	0.5x
Wed, 26 Nov 2025	AU$10.9b	AU$19.2b	AU$80.8m	47.1x	135x	0.6x
Fri, 24 Oct 2025	AU$9.8b	AU$19.4b	AU$82.7m	110.1x	119.1x	0.5x
Sun, 21 Sep 2025	AU$10.9b	AU$19.4b	AU$82.7m	93.1x	131.5x	0.6x
Tue, 19 Aug 2025	AU$12.1b	AU$18.7b	AU$22.8m	172.3x	532x	0.6x
Thu, 17 Jul 2025	AU$11.6b	AU$18.7b	AU$22.4m	160.5x	515.6x	0.6x
Sat, 14 Jun 2025	AU$11.3b	AU$18.7b	AU$22.4m	166.9x	502.3x	0.6x
Mon, 12 May 2025	AU$11.3b	AU$18.7b	AU$22.4m	173.3x	502.6x	0.6x
Wed, 09 Apr 2025	AU$10.3b	AU$18.7b	AU$22.4m	189.6x	459.5x	0.6x
Fri, 07 Mar 2025	AU$10.7b	AU$18.7b	AU$31.1m	133.4x	342.1x	0.6x
Sun, 02 Feb 2025	AU$10.5b	AU$18.1b	AU$234.0m	34.9x	44.8x	0.6x
Tue, 31 Dec 2024	AU$10.4b	AU$18.1b	AU$234.0m	34.7x	44.6x	0.6x
Thu, 28 Nov 2024	AU$11.8b	AU$18.1b	AU$234.0m	37.3x	50.5x	0.7x
Sat, 26 Oct 2024	AU$12.2b	AU$18.1b	AU$234.0m	37x	52.3x	0.7x
Mon, 23 Sep 2024	AU$11.8b	AU$18.1b	AU$234.0m	36.7x	50.2x	0.6x
Wed, 21 Aug 2024	AU$11.7b	AU$16.4b	AU$251.1m	42.9x	46.4x	0.7x
Fri, 19 Jul 2024	AU$11.7b	AU$16.4b	AU$251.1m	43.5x	46.6x	0.7x
Sun, 16 Jun 2024	AU$11.9b	AU$16.4b	AU$251.1m	45.5x	47.3x	0.7x
Tue, 14 May 2024	AU$12.5b	AU$16.4b	AU$251.1m	45.9x	49.8x	0.8x
Thu, 11 Apr 2024	AU$13.1b	AU$16.4b	AU$251.1m	39.9x	52.3x	0.8x
Sat, 09 Mar 2024	AU$13.7b	AU$16.4b	AU$251.1m	36.2x	54.4x	0.8x
Mon, 05 Feb 2024	AU$15.0b	AU$17.2b	AU$255.4m	35.1x	58.7x	0.9x
Wed, 03 Jan 2024	AU$15.2b	AU$17.2b	AU$255.4m	35.4x	59.7x	0.9x
Fri, 01 Dec 2023	AU$14.3b	AU$17.2b	AU$255.4m	33.6x	55.8x	0.8x
Sun, 29 Oct 2023	AU$14.1b	AU$17.2b	AU$255.4m	33.6x	55.4x	0.8x
Tue, 26 Sep 2023	AU$14.7b	AU$17.2b	AU$255.4m	34.5x	57.7x	0.9x
Thu, 24 Aug 2023	AU$15.5b	AU$16.6b	AU$246.7m	26.8x	62.7x	0.9x
Sat, 22 Jul 2023	AU$15.7b	AU$16.5b	AU$211.1m	27x	74.2x	0.9x
Mon, 19 Jun 2023	AU$15.9b	AU$16.5b	AU$211.1m	26.4x	75.4x	1x
Wed, 17 May 2023	AU$16.6b	AU$16.5b	AU$211.1m	26.2x	78.4x	1x

Current Industry PE

There are only 3 companies in the Australian Health Care Facilities industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.

Past Earnings Growth

The earnings for companies in the Health Care Facilities industry have grown 15% per year over the last three years.
Revenues for these companies have grown 7.9% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Australian Healthcare Facilities compare with similar industries?


AU Market	0.20%
Healthcare	-2.43%
Healthcare Services	-0.82%
Healthcare Facilities	-3.87%
Healthcare Distributors	1.41%
Healthcare Services	-4.17%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

	Company	Last Price	7D	1Y	Valuation
	MVF Monash IVF Group	AU$0.74	1.4% +AU$3.9m	-10.8%	PE19.2x

Company

Last Price

Valuation

MVF Monash IVF Group

AU$0.74

1.4%
+AU$3.9m

-10.8%

PE19.2x

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited (ASX:MVF).

WHSP Holdings Limited (ASX:SOL) and Genesis Capital entered into a non-binding indicative proposal to acquire remaining 80.4% stake in Monash IVF Group Limited (ASX:MVF) for approximately AUD 250 million on November 24, 2025. A cash consideration valued at AUD 0.8 per share and will be paid by WHSP Holdings Limited and Genesis Capital. As part of consideration, an AUD 0.85 million is paid towards Performance Rights and AUD 250.61 million is paid towards common equity of Monash IVF Group Limited. The transaction is contingent upon exclusive due diligence, customary transaction documentation negotiation and execution, unanimous Monash IVF Group Limited recommendation, and final internal approval from WHSP Holdings Limited and Genesis Capital for a binding proposal and transaction documentation. The deal has been rejected by the board of Monash IVF Group Limited due to the Offer Price being at a substantial discount to comparable IVF transactions in the Australian market, the Proposal remaining conditional and requiring further due diligence and access to senior management and key employees, and uncertainty regarding the financing arrangements proposed by the Consortium. As of April 13, 2026 Monash IVF Group Limited has now received a revised, unsolicited, conditional and non-binding indicative proposal from WHSP Holdings Limited (ASX:SOL) and Genesis Capital. The indicative cash price offered to shareholders under the Proposal is AUD 0.90 per share. As part part of consideration AUD 281.93 million is paid towards common equity and AUD 1.68 million is paid towards performance rights. It should be noted that there is no certainty that the discussions with the Consortium will result in any transaction. If there are material developments in the future, Monash IVF will inform shareholders as required under its continuous disclosure obligations. The deal is conditional upon exclusive due diligence, including a 4-week period of exclusivity with no fiduciary exceptions, negotiation and execution of transaction documentation on 'customary terms', including a no material adverse change condition, unanimous recommendation of the Monash IVF Board of the Proposal and final internal approval from the relevant Consortium Members for a final binding proposal and entry into transaction documentation. Macquarie Capital Limited acted as financial advisor for Monash IVF Group Limited. Clayton Utz acted as legal advisor for Monash IVF Group Limited. WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited (ASX:MVF) on April 20, 2026. Monash IVF Group Limited announced that its Board has unanimously rejected the revised non-binding proposal from Genesis Capital and Soul Patts to acquire the company for AUD 0.90 per share, stating the offer undervalues the company but remains open to a higher bid. This captures the rejection, the offer price, the reason, and the fact that the door remains open for a higher offer, which are the key takeaways for our tracking purposes.

Australian (ASX) Healthcare Facilities Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

New minor risk - Insider selling

RHC: Dividend Payouts And Possible UK Exit Will Shape Balanced Outlook

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited (ASX:MVF).